Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab.
Klarenbeek NB, Güler-Yüksel M, van der Heijde DM, Hulsmans HM, Kerstens PJ, Molenaar TH, de Sonnaville PB, Huizinga TW, Dijkmans BA, Allaart CF. Klarenbeek NB, et al. Ann Rheum Dis. 2010 Dec;69(12):2107-13. doi: 10.1136/ard.2010.131201. Epub 2010 Jul 7. Ann Rheum Dis. 2010. PMID: 20610442 Clinical Trial.
A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study.
van der Kooi E, Klarenbeek NB, Güler-Yüksel M, Kerstens PJ, van der Lubbe PA, Westedt ML, ten Wolde S, Huizinga TW, Dijkmans BA, Allaart CF. van der Kooi E, et al. Among authors: klarenbeek nb. Ann Rheum Dis. 2011 Jan;70(1):168-71. doi: 10.1136/ard.2010.133132. Epub 2010 Nov 29. Ann Rheum Dis. 2011. PMID: 21115551
Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study.
van den Broek M, Klarenbeek NB, Dirven L, van Schaardenburg D, Hulsmans HM, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. van den Broek M, et al. Among authors: klarenbeek nb. Ann Rheum Dis. 2011 Aug;70(8):1389-94. doi: 10.1136/ard.2010.147751. Epub 2011 Apr 24. Ann Rheum Dis. 2011. PMID: 21515916 Clinical Trial.
Simplified versions of the original disease activity score: validation in the BeSt trial.
Koevoets R, Klarenbeek NB, Güler-Yüksel M, van Oosterhout M, van Krugten MV, Kerstens PJ, Huizinga TW, Dijkmans BA, van der Heijde DM, Allaart CF. Koevoets R, et al. Among authors: klarenbeek nb. Ann Rheum Dis. 2011 Aug;70(8):1471-4. doi: 10.1136/ard.2010.149146. Epub 2011 May 8. Ann Rheum Dis. 2011. PMID: 21551508 Clinical Trial.
The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study.
van den Broek M, Dirven L, Klarenbeek NB, Molenaar TH, Han KH, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. van den Broek M, et al. Among authors: klarenbeek nb. Ann Rheum Dis. 2012 Feb;71(2):245-8. doi: 10.1136/annrheumdis-2011-200379. Epub 2011 Nov 21. Ann Rheum Dis. 2012. PMID: 22110122 Clinical Trial.
Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial.
Klarenbeek NB, van der Kooij SM, Huizinga TJ, Goekoop-Ruiterman YP, Hulsmans HM, van Krugten MV, Speyer I, de Vries-Bouwstra JK, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. Klarenbeek NB, et al. Ann Rheum Dis. 2010 Jul;69(7):1342-5. doi: 10.1136/ard.2009.124180. Epub 2010 May 14. Ann Rheum Dis. 2010. PMID: 20472597 Clinical Trial.
30 results